Results

Total Results: over 10,000 records

Showing results for "harms".

9941. Medication Therapy Management | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/medication-therapy-management/research-protocol
      July 24, 2013 - likely to benefit from MTM services and to what degree, and what types of patients may be at risk of harms … for KQ 4 in the PICOTS Rephrasing KQ 5 to make the response conditional on identifying whether any harms … Question 5 Are there harms of MTM, and if so, what are they? Analytic Framework Figure 1. … Health care utilization (hospitalizations, emergency department visits, and physician office visits) Harms … strength of the body of evidence to answer the KQs on the comparative effectiveness, efficacy, and harms

9942. Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
      November 08, 2011 - or dose reduction, which is usually based on a medical plan or a desire to avoid treatment-related harms … Question 4 What are the harms associated with hepatitis C antiviral treatment adherence interventions … In addition, the quality assessment of adverse effects and harms data will be informed by the Methods … Assessing Applicability Judgments of applicability for each outcome (including harms) will be performed … Question 3 What are the harms associated with hepatitis C antiviral treatment adherence interventions

9943. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
      July 01, 2012 - will influence treatment decisions, or predicting response to treatments (either effectiveness or harms … family members, psychological distress and possible stigmatization or discrimination are potential harms … For these potential harms, analysts should take into account whether the testing is for inherited or … acquired genetic mutations, since these factors influence the potential for harms. … 5: What are the harms associated with testing for CYP450 polymorphisms and subsequent management options

9944. home-based-care-protocol-141119 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/home-based-care_research-protocol.pdf
      November 19, 2014 - in care for patients with chronic conditions and disabilities, uncertainties remain about potential harms … have frequently highlighted this lack of detailed information about the intervention and potential harms … Harms include negative effects of HPBC in any of the outcome categories. … Analytic framework for Home-Based Primary Care Interventions Harms: Adverse Effects … The key questions are designed to assess the comparative effectiveness and harms by patient demographics

9945. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
      September 01, 2011 - Newer agents, such as asenapine, iloperidone and paliperidone cannot be assumed to have efficacy and harms … This requires knowing the evidence about benefits, harms and applicability, and using clinical judgment … These harms should be assumed for the newer agents as well. … There is a "class effect" of these harms for almost every d2 blocking agent. … There is simply a lack of evidence; the potential for harms (as well as benefits) still exists.

9946. home-based-care-protocol-141119 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/home-based-care_research-protocol.pdf
      November 19, 2014 - in care for patients with chronic conditions and disabilities, uncertainties remain about potential harms … have frequently highlighted this lack of detailed information about the intervention and potential harms … Harms include negative effects of HPBC in any of the outcome categories. … Analytic framework for Home-Based Primary Care Interventions Harms: Adverse Effects … The key questions are designed to assess the comparative effectiveness and harms by patient demographics

9947. Effectiveness of Practice-based Interventions Addressing Concomitant Mental Health and Chronic Medical Conditions in the Primary Care Setting | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/depression-chronic-conditions-interventions/research-protocol
      December 01, 2019 - following will be addressed in the context of the studies examined for KQs 1 and 2: Question 3 What harms … include the following: Adverse effects of pharmacotherapy Other harms as reported Timing … Other mental health outcomes Chronic medical and general health outcomes Costs of interventions Harms … strength of the body of evidence to answer the KQs on the comparative effectiveness, efficacy, and harms … with heterogeneity of treatment effect, measurement of absolute (rather than relative) benefits and harms

9948. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
      September 01, 2011 - Newer agents, such as asenapine, iloperidone and paliperidone cannot be assumed to have efficacy and harms … This requires knowing the evidence about benefits, harms and applicability, and using clinical judgment … These harms should be assumed for the newer agents as well. … There is a "class effect" of these harms for almost every d2 blocking agent. … There is simply a lack of evidence; the potential for harms (as well as benefits) still exists.

9949. Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
      December 01, 2019 - or dose reduction, which is usually based on a medical plan or a desire to avoid treatment-related harms … Question 4 What are the harms associated with hepatitis C antiviral treatment adherence interventions … of HCV Adverse Effects Paradoxical decrease in adherence Increase in treatment related harms … In addition, the quality assessment of adverse effects and harms data will be informed by the Methods … Question 3 What are the harms associated with hepatitis C antiviral treatment adherence interventions

9950. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
      July 01, 2012 - will influence treatment decisions, or predicting response to treatments (either effectiveness or harms … family members, psychological distress and possible stigmatization or discrimination are potential harms … For these potential harms, analysts should take into account whether the testing is for inherited or … acquired genetic mutations, since these factors influence the potential for harms. … 5: What are the harms associated with testing for CYP450 polymorphisms and subsequent management options

9951. Trauma-Informed Care | Agency for Healthcare Research and Quality
      www.ahrq.gov/ncepcr/tools/healthier-pregnancy/fact-sheets/trauma.html
      April 01, 2016 - Trauma-Informed Care Nearly one in three adult women experience at least one physical assault by a partner during adulthood.  One out of every 6 American women has been the victim of an attempted or completed rape in her lifetime By the age of 13… at least one out of every five girls are sexually abused …

9952. Dignity Health Expands Use of AHRQ's CANDOR Toolkit | Agency for Healthcare Research and Quality
      www.ahrq.gov/news/newsroom/case-studies/201620.html
      February 01, 2017 - Dignity Health Expands Use of AHRQ's CANDOR Toolkit Search All Impact Case Studies February 2017 Dignity Health, one of the Nation's largest hospital systems, has expanded its use of AHRQ's Communication and Optimal Resolution (CANDOR) toolkit to 12 hospitals in California. The toolkit helps hospitals, he…

9953. CommonSpirit Health Expands CANDOR Toolkit Across Entire Health System | Agency for Healthcare Research and Quality
      www.ahrq.gov/news/newsroom/case-studies/202104.html
      October 01, 2021 - CommonSpirit Health Expands CANDOR Toolkit Across Entire Health System Search All Impact Case Studies October 2021 CommonSpirit Health, one of the Nation's largest health systems, serving 21 States, is expanding its use of AHRQ's  Communication and Optimal Resolution (CANDOR) toolkit  across its entire netw…

9954. To err is human, to apologize is hard. | PSNet
      psnet.ahrq.gov/issue/err-human-apologize-hard
      September 28, 2022 - Commentary To err is human, to apologize is hard. Citation Text: Krakower TM. To err Is human, to apologize is hard. JAMA. 2021;326(3):223-224. doi:10.1001/jama.2021.10840. Copy Citation Format: DOI Google Scholar BibTeX EndNote X3 XML EndNote 7 XML Endnote tagged PubMedId…

9955. Condition concern: an innovative response system for enhancing hospitalized patient care and safety. | PSNet
      psnet.ahrq.gov/issue/condition-concern-innovative-response-system-enhancing-hospitalized-patient-care-and-safety
      April 24, 2018 - Commentary Condition concern: an innovative response system for enhancing hospitalized patient care and safety. Citation Text: Baird SK, Turbin LB. Condition concern: an innovative response system for enhancing hospitalized patient care and safety. J Nurs Care Qual. 2011;26(3):199-207. d…

9956. Safe Practices for Better Healthcare: 2010 Update. | PSNet
      psnet.ahrq.gov/issue/safe-practices-better-healthcare-2010-update
      March 23, 2012 - Book/Report Safe Practices for Better Healthcare: 2010 Update. Citation Text: Safe Practices for Better Healthcare: 2010 Update. Washington, DC: National Quality Forum; 2010. Copy Citation Save Save to your library Print Download PDF Share …

9957. To disclose or not to disclose radiologic errors: should "patient-first" supersede radiologist self-interest? | PSNet
      psnet.ahrq.gov/issue/disclose-or-not-disclose-radiologic-errors-should-patient-first-supersede-radiologist-self
      October 23, 2018 - Commentary To disclose or not to disclose radiologic errors: should "patient-first" supersede radiologist self-interest? Citation Text: Berlin L. To disclose or not to disclose radiologic errors: should "patient-first" supersede radiologist self-interest? Radiology. 2013;268(1):4-7. doi…

9958. Preventing errors with high-risk medications. | PSNet
      psnet.ahrq.gov/issue/preventing-errors-high-risk-medications
      May 20, 2020 - Newspaper/Magazine Article Preventing errors with high-risk medications. Citation Text: Preventing errors with high-risk medications. Wiley F. Drug Topics. August 2019;1633:16-18. Copy Citation Save Save to your library Print Download PDF Share …

9959. Error disclosure and apology in radiology: the case for further dialogue. | PSNet
      psnet.ahrq.gov/issue/error-disclosure-and-apology-radiology-case-further-dialogue
      October 19, 2022 - Commentary Error disclosure and apology in radiology: the case for further dialogue. Citation Text: Brown SD, Bruno MA, Shyu JY, et al. Error Disclosure and Apology in Radiology: The Case for Further Dialogue. Radiology. 2019;293(1):30-35. doi:10.1148/radiol.2019190126. Copy Citation …

9960. What constitutes effective team communication after an error? | PSNet
      psnet.ahrq.gov/issue/what-constitutes-effective-team-communication-after-error
      September 23, 2020 - Commentary What constitutes effective team communication after an error? Citation Text: Hart WM, Doerr P, Qian Y, et al. What constitutes effective team communication after an error? AMA J Ethics. 2020;22(4):E298-E304. doi:10.1001/amajethics.2020.298. Copy Citation Format: …